Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Envista Holdings's FCF Margin % or its related term are showing as below:
MEX:NVST'
s FCF Margin % Range Over the Past 10 Years
Min: 4.16 Med: 11.8 Max: 13.99
Current: 7.94
During the past 10 years, the highest FCF Margin % of Envista Holdings was 13.99%. The lowest was 4.16%. And the median was 11.80%.
MEX:NVST's FCF Margin % is ranked better than 69.08% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs MEX:NVST: 7.94
Envista Holdings FCF Margin % Related Terms
Envista Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for Envista Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NVST vs MMSI, MMED, STVN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Envista Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envista Holdings (MEX:NVST) has a FCF Margin % of -2.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Envista Holdings and its competitors. Over the past decade, Envista Holdings' FCF Margin % has ranged from 4.16 to 13.99. According to the industry distribution chart, Envista Holdings ranks #252 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 30.9%.
Is Envista Holdings' FCF Margin % too high?
Envista Holdings' current FCF Margin % is -2.24%. Over the past 10 years, this metric has ranged from a low of 4.16 to a high of 13.99. Based on the distribution chart, Envista Holdings ranks #252 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Envista Holdings has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' FCF Margin % compare to MMSI and MMED?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #252 out of 815 companies for FCF Margin %. This puts Envista Holdings in the upper half of its industry. Historically, Envista Holdings' own FCF Margin % has ranged from 4.16 to 13.99 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Envista Holdings and its competitors. Envista Holdings's current FCF Margin % is -2.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Envista Holdings (MEX:NVST) has a current FCF Margin % of -2.24%. The stock's GF Value™ is MXN332.83, compared to a current price of MXN370.00 — trading 11.2% above its estimated fair value. The current FCF Margin % is -2.24%. Envista Holdings' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Envista Holdings (MEX:NVST), the current FCF Margin % is -2.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (MEX:NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of MXN370.00 is trading 11.2% above its estimated GF Value™ of MXN332.83.
Key valuation signals for MEX:NVST:
FCF Margin %: -2.24%
GF Value™: MXN332.83 vs. price of MXN370.00 (11.2% above fair value)
No single metric tells the full story. See the MEX:NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for MEX:NVST
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NVST has been successfully added to your 
